BET 2: Hydroxychloroquine in the treatment of COVID-19.

Howard, Laura; Baombe, Janos; Reynard, Charles

Howard, Laura; Baombe, Janos; Reynard, Charles.

Howard L; Emergency Department, Manchester University NHS Foundation Trust, Manchester, UK.
Baombe J; Emergency Department, Manchester University NHS Foundation Trust, Manchester, UK.
Reynard C; Emergency Department, Manchester University NHS Foundation Trust, Manchester, UK.

Emerg Med J ; 37(7): 451-453, 2020 Jul.

Article in English | MEDLINE | ID: covidwho-629336

Subject(s)

Betacoronavirus/isolation & purification; Coronavirus Infections/drug therapy; Hydroxychloroquine/administration & dosage; Pneumonia, Viral/drug therapy; COVID-19; Coronavirus Infections/diagnosis; Coronavirus Infections/virology; Humans; Hydroxychloroquine/adverse effects; Male; Middle Aged; Observational Studies as Topic; Pandemics; Pneumonia, Viral/diagnosis; Pneumonia, Viral/virology; RNA, Viral/isolation & purification; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; COVID-19 Drug Treatment

Keywords

emergency care systems

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Betacoronavirus / Hydroxychloroquine Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Limits: Humans / Male / Middle aged Language: English Journal: Emerg Med J Journal subject: Emergency Medicine Year: 2020 Document Type: Article Affiliation country: Emermed-2020-210221.3

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google